Radium Ra 223 dichloride Terminated Phase 3 Trials for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04237584A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients